about
The impact of TNF superfamily molecules on overall survival in acute myeloid leukaemia: correlation with biological and clinical features.BAFF and APRIL as TNF superfamily molecules and angiogenesis parallel progression of human multiple myeloma.Vitamin A family compounds, estradiol, and docetaxel in proliferation, apoptosis and immunocytochemical profile of human ovary endometrioid cancer cell line CRL-11731.The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel.Prognostic significance of ligands belonging to tumour necrosis factor superfamily in acute lymphoblastic leukaemia.The evaluation of angiogenesis and matrix metalloproteinase-2 secretion in bone marrow of multiple myeloma patients before and after the treatment.Evaluation of TNF superfamily molecules in multiple myeloma patients: correlation with biological and clinical features.Plasma concentration of protein Z and protein Z-dependent protease inhibitor in patients with haemophilia A.Assessment of expression of selected Bcl-2 family proteins in lymphoid infiltration in patients with B-cell chronic lymphocytic leukaemia treated with nucleoside analogues.Bone marrow megakaryocytes, soluble P-selectin and thrombopoietic cytokines in multiple myeloma patients.Serum sICAM, sVCAM and sE-selectin levels in colorectal cancer patients.Angiogenesis in gliomas.Relationship between tumour necrosis factor-related apoptosis inducing ligand (TRAIL) and vascular endothelial growth factor in human multiple myeloma patientsThe levels of sMUC-1 in patients with multiple myeloma
P50
Q34798476-5C3DB80B-F43D-47D9-B0EB-098FB19AADE9Q37622417-E80236F9-B0AF-4BB3-8723-59E168382121Q39752978-ACA5B7A6-A1B3-4295-A24D-635117C2A524Q39865012-2C3490F6-9340-443C-B908-ADC4F555F40FQ41591499-2D8E364A-EA43-4104-A23C-B63918449C8BQ43963156-1C5BC6A4-C5F9-4EFD-BC66-ED4BE89F9BABQ45227203-BA0D695B-0E00-4F73-9FC1-DF2DB24BABBFQ45883976-07D4EE3A-098A-4832-A8F7-60C613E92769Q46213982-B5C88921-44D4-4520-BE6E-6CD150278E92Q48006029-B4A996EA-0267-4BFC-A749-0352D6D58B44Q53314414-1886EFAB-EBE0-4CA5-A3BF-6A7BA1F20290Q55467063-4818A664-D584-4761-AACB-6ECC0EA408B5Q61943533-8E6B1673-D642-4032-AC9E-6420374431D3Q62590217-BC236343-359D-469A-9327-37687B828187
P50
description
researcher ORCID ID = 0000-0003-4187-3185
@en
name
D Lemancewicz
@ast
D Lemancewicz
@en
D Lemancewicz
@ga
D Lemancewicz
@nl
Dorota Lemancewicz
@ca
Dorota Lemancewicz
@cs
Dorota Lemancewicz
@es
Dorota Lemancewicz
@gl
Dorota Lemancewicz
@hr
Dorota Lemancewicz
@hsb
type
label
D Lemancewicz
@ast
D Lemancewicz
@en
D Lemancewicz
@ga
D Lemancewicz
@nl
Dorota Lemancewicz
@ca
Dorota Lemancewicz
@cs
Dorota Lemancewicz
@es
Dorota Lemancewicz
@gl
Dorota Lemancewicz
@hr
Dorota Lemancewicz
@hsb
prefLabel
D Lemancewicz
@ast
D Lemancewicz
@en
D Lemancewicz
@ga
D Lemancewicz
@nl
Dorota Lemancewicz
@ca
Dorota Lemancewicz
@cs
Dorota Lemancewicz
@es
Dorota Lemancewicz
@gl
Dorota Lemancewicz
@hr
Dorota Lemancewicz
@hsb
P1153
55904276700
P1412
P1559
Dorota Lemancewicz
@pl
P21
P214
95152682579523312319
P27
P31
P496
0000-0003-4187-3185
P735
P7859
viaf-95152682579523312319